Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Classement en actions #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Prix de l'action
$1.50
Dernière synchronisation: 2026-09-21
Capitalisation boursière
$3.63M
Changement (1 jour)
-4.46%
Changement (1 an)
-72.68%
Pays
MY
Échange BioNexus Gene Lab Corp. (BGLC)

Catégorie

Bénéfices pour BioNexus Gene Lab Corp. (BGLC)
Bénéfices en Jun 2026 TTM : $-2.58M
Selon les derniers rapports financiers de BioNexus Gene Lab Corp., les bénéfices actuels de l'entreprise sont de $-2.58M. En 2023, l'entreprise a réalisé un bénéfice de $-2.61M, une diminution par rapport à celui de 2022 qui était de $-303.66K. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour BioNexus Gene Lab Corp. de 2016 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-2.58M 61.47%
2024 $-1.59M -38.84%
2023 $-2.61M 758.71%
2022 $-303.66K -129.12%
2021 $1.04M -17.40%
2020 $1.26M -557.92%
2019 $-275.71K -560.27%
2018 $59.90K -150.16%
2017 $-119.41K 14,201.08%
2016 $-835.00 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$2.69B -104,366.42%
US
$1.78B -69,051.75%
US
- -
US
$934.20M -36,377.72%
US
- -
US